News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
FDA
Decision Due Soon on Eli Lilly and Company (JOBS), Daiichi Sankyo Co Ltd. Blood Thinner
September 22, 2008
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
NEW YORK, Sept 21 (Reuters) - Two large drug makers, Eli Lilly and Co and Daiichi Sankyo Co Ltd, face a critical U.S. decision this week on their shared blood-clot preventer that could dramatically boost their bottom lines.
Twitter
LinkedIn
Facebook
Email
Print
FDA
Approvals
Regulatory
MORE ON THIS TOPIC
Approvals
GSK’s Blenrep Makes Comeback With FDA Nod for Third-Line Multiple Myeloma
October 24, 2025
·
2 min read
·
Tristan Manalac
Job Trends
8 Companies Hiring Now in Regulatory
October 23, 2025
·
2 min read
·
Angela Gabriel
Podcast
Novo Board Upended, ESMO Excitement, FDA Awards, Replimune’s U-Turn
October 22, 2025
·
1 min read
·
Heather McKenzie
FDA
Krystal Biotech’s FDA Platform Designation Pushes Limits of the Award
October 21, 2025
·
2 min read
·
Dan Samorodnitsky